Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

PD GENEration

Parkinson's Foundation

R. N. Alcalay

Myths and Misconceptions About Parkinson Disease: What Is a Role of …

Mayo Clinic Proceedings

E. Ahlskog

Embracing Aging: Helping Our Loved Ones, Helping Ourselves

Pacific Neuroscience Institute

S. Kaiser, A. Effinger

Unmet Needs of Women Living WithParkinson’s Disease: Research & Ma…

Indu Subramanian

Cognitive Disorders

ZINCARE

M. Mataa

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Parkinson’s Disease: The Exercise Prescription and Rationale

University of Utah Neurology

D. M. Corcos

Updates in the Diagnosis of Parkinson's Disease (PD)

Pacific Neuroscience Institute

M. Petrossian

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Aducanumab: What Neurologists Should Know - Clinical Impact, Indicat…

Northwestern Medicine Neurology and Neurosurgery

I. Grant

Neuropsychological Assessment in Dementia Diagnosis

Northwestern Medicine Neurology and Neurosurgery

S. Weintraub

Not Your Grandmother's Dopamine: Pairing Clinical Studies With Dopam…

PMD Alliance

F. L. Pagán

Advanced Therapies for Parkinson Disease

University of Colorado Department of Neurology

A. Baumgartner

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Updates in Dementia

2023 Conference Coverage

P. Tipton

Preventing Cognitive Decline with Lithium

Psychiatry Redefined

J. Greenblatt

Alzheimer's: Clinical Pearls

Lawrence Robbins